MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Functional screening identifies miRNAs inducing cardiac regeneration
Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
The pathophysiology of heart failure with preserved ejection fraction
Borlaug, B. A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.83 · Cited by 726
Hypothalamic stem cells control ageing speed partly through exosomal miRNAs
Zhang, Y., Kim, M. S., Jia, B., Yan, J., Zuniga-Hertz, J. P., Han, C., & Cai, D. (2017) · Nature · doi:10.1038/nature23282 · Cited by 564
“We considered secretory miRNAs, as recent research has emerged to link miRNAs to stem cell function 28,29 as well as aging 30 .”
Cardiac Fibrosis in Patients With Atrial Fibrillation
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1313 · Cited by 552
“Aging-induced expression of miR-34a and inhibition of PNUTS is associated with telomere shortening, deoxyribonucleic acid damage, cardiomyocyte apoptosis, and impaired functional recovery after ischemic injury (47).”
Paul, A., Hasan, A., Kindi, H. A., Gaharwar, A. K., Rao, V. T. S., Nikkhah, M., Shin, S. R., Krafft, D., Dokmeci, M. R., Shum-Tim, D., et al. (2014) · ACS Nano · doi:10.1021/nn5020787 · Cited by 535
The biological functions of miRNAs: lessons from in vivo studies
Vidigal, J. A., & Ventura, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.004 · Cited by 488
Pan, Y., Hui, X., Hoo, R. L. C., Ye, D., Chan, C. Y. C., Feng, T., Wang, Y., Lam, K. S. L., & Xu, A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123069 · Cited by 493
Hippo signaling impedes adult heart regeneration
Heallen, T., Morikawa, Y., Leach, J., Tao, G., Willerson, J. T., Johnson, R. L., & Martin, J. F. (2013) · Development · doi:10.1242/dev.102798 · Cited by 458
The Role of miRNAs in Regulating Gene Expression Networks
Gurtan, A. M., & Sharp, P. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.007 · Cited by 443
“Consistent with this possibility, a recent study demonstrated a role for miR-34 in promoting age-associated cardiomyocyte cell death through repression of PNUTS, a regulator of apoptosis and DNA damage response.(69) Additional analyses of miR-34 KO animals in various tumor models with greater numbers of mice may uncov…”
MicroRNAs in Cardiovascular Disease
Barwari, T., Joshi, A., & Mayr, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.945 · Cited by 445
“Along similar lines, inhibition of miR-34a improved cardiac function after MI in mice, attenuating cardiomyocyte apoptosis and telomere shortening (32).”
BackgroundAging and Autophagy in the Heart
Shirakabe, A., Ikeda, Y., Sciarretta, S., Zablocki, D. K., & Sadoshima, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.307474 · Cited by 441
“For example, growth factors, miRNA, and exosomes excreted from distal organs may mediate autophagy and inhibit senescence in the heart after reaching the heart through the systemic circulation.(197) Thus, where such is likely to be the case for a particular antisenescence intervention, further investigation is needed…”
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Poller, W., Dimmeler, S., Heymans, S., Zeller, T., Haas, J., Karakas, M., Leistner, D.-M., Jakob, P., Nakagawa, S., Blankenberg, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx165 · Cited by 408
“Inhibition of miR-15 or miR-34 family members also improved neovascularization after ischaemia.(23,101) Members of the miR-17 92 cluster, specifically”
BackgroundSelf-citationRational Engineering of a Dynamic, Entropy‐Driven DNA Nanomachine for Intracellular MicroRNA Imaging
Liang, C., Ma, P., Liu, H., Guo, X., Yin, B., & Ye, B. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704147 · Cited by 389
microRNAs in Cardiovascular Diseases
Condorelli, G., Latronico, M. V. G., & Cavarretta, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.050 · Cited by 375
“Indeed, further studies demonstrated that miRNAs control fundamentally all critical aspects of cardiovascular biology, such as angiogenesis (30), metabolism (31–34), aging (35), and also the inflammatory component of myocardial remodeling: for instance, miR-155 was found to control macrophage activity, thereby regulat…”
BackgroundThe epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
“Altered expression of various miRNAs, has been linked to age-related cardiovascular problems (Boon et al., 2013; Boon et al., 2011; Menghini et al., 2009; Olivieri et al., 2013; Vasa-Nicotera et al., 2011) (Table 3).”
BackgroundMicroRNAs in myocardial infarction
Boon, R. A., & Dimmeler, S. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.207 · Cited by 369
Self-citationCappetta, D., De Angelis, A., Sapio, L., Prezioso, L., Illiano, M., Quaini, F., Rossi, F., Berrino, L., Naviglio, S., & Urbanek, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1521020 · Cited by 350
The p53/miR-34 axis in development and disease
Rokavec, M., Li, H., Jiang, L., & Hermeking, H. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju003 · Cited by 354
“, 2013) and in vivo silencing or genetic deletion of miR-34a in mouse reduced age-associated cardiomyocyte cell death (Boon et al., 2013).”
BackgroundInfluentialSelf-citationSenescence mechanisms and targets in the heart
Chen, M. S., Lee, R. T., & Garbern, J. C. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab161 · Cited by 327
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 334
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 332
Self-citationPathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
“The critical role of miR-34a in cardiac ageing and function made it to be selected as a target for treating myocardial infarction [17, 144].”
BackgroundKrzeszinski, J. Y., Wei, W., Huynh, H., Jin, Z., Wang, X., Chang, T.-C., Xie, X.-J., He, L., Mangala, L. S., Lopez-Berestein, G., et al. (2014) · Nature · doi:10.1038/nature13375 · Cited by 303
RetractedShao, L., Zhang, Y., Lan, B., Wang, J., Zhang, Z., Zhang, L., Xiao, P., Meng, Q., Geng, Y.-J., Yu, X.-Y., et al. (2017) · BioMed Research International · doi:10.1155/2017/4150705 · Cited by 300
“Previous studies showed that inhibition of miR-34 expression in vivo using LNA-based antimiRs or antagomiRs improved cardiomyocyte survival after MI and thereby preserved cardiac contractile function [35, 36].”
BackgroundLegchenko, E., Chouvarine, P., Borchert, P., Fernandez-Gonzalez, A., Snay, E., Meier, M., Maegel, L., Mitsialis, S. A., Rog-Zielinska, E. A., Kourembanas, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0303 · Cited by 295
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling
Horn, M. A., & Trafford, A. W. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.005 · Cited by 275
Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases
Li, Y., Lui, K. O., & Zhou, B. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0023-y · Cited by 289
Targeting Age-Related Pathways in Heart Failure
Li, H., Hastings, M. H., Rhee, J., Trager, L. E., Roh, J. D., & Rosenzweig, A. (2020) · Circulation Research · doi:10.1161/circresaha.119.315889 · Cited by 266
Alternative mechanisms of miR-34a regulation in cancer
Slabáková, E., Culig, Z., Remšík, J., & Souček, K. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.495 · Cited by 264
Agostini, M., & Knight, R. A. (2014) · Oncotarget · doi:10.18632/oncotarget.1825 · Cited by 254
“Systemic overexpression of miR-34, which is broadly expressed and regulates physiological processes, could target genes in healthy tissues and cause side effects such as cardiovascular disease, although this may be minimised by the use of the particular liposome formulation [97].”
BackgroundMikhed, Y., Daiber, A., & Steven, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715918 · Cited by 257
“inhibition reduces cell death and fibrosis associated with post MI conditions [199].”
BackgroundMiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
Nagpal, V., Rai, R., Place, A. T., Murphy, S. B., Verma, S. K., Ghosh, A. K., & Vaughan, D. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018174 · Cited by 244
Zacchigna, S., Paldino, A., Falcão-Pires, I., Daskalopoulos, E. P., Dal Ferro, M., Vodret, S., Lesizza, P., Cannatà, A., Miranda-Silva, D., Lourenço, A. P., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa110 · Cited by 226
MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction
Yang, Y., Cheng, H.-W., Qiu, Y., Dupee, D., Noonan, M., Lin, Y.-D., Fisch, S., Unno, K., Sereti, K.-I., & Liao, R. (2015) · Circulation Research · doi:10.1161/circresaha.117.305962 · Cited by 228
miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart
Bernardo, B. C., Ooi, J. Y., Lin, R. C., & McMullen, J. R. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.107 · Cited by 226
Oxidative Stress and Epigenetic Regulation in Ageing and Age-Related Diseases
Cencioni, C., Spallotta, F., Martelli, F., Valente, S., Mai, A., Zeiher, A., & Gaetano, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917643 · Cited by 223
“The authors further demonstrated that the miR-34a-PNUTS axis rules ischemia reperfusion injury after acute myocardial infarction, a phenomenon strictly associated with oxidative stress damage [42].”
BackgroundInfluentialSelf-citationFulzele, S., Mendhe, B., Khayrullin, A., Johnson, M., Kaiser, H., Liu, Y., Isales, C. M., & Hamrick, M. W. (2019) · Aging · doi:10.18632/aging.101874 · Cited by 215
“miR-34a is known to induce senescence in vascular smooth muscle cells and cardiomyocytes and to increase cardiac fibrosis [34, 35].”
BackgroundDrug and cell delivery for cardiac regeneration
Hastings, C. L., Roche, E. T., Ruiz-Hernandez, E., Schenke-Layland, K., Walsh, C. J., & Duffy, G. P. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.006 · Cited by 200
Moghaddam, A. S., Afshari, J. T., Esmaeili, S.-A., Saburi, E., Joneidi, Z., & Momtazi-Borojeni, A. A. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.03.016 · Cited by 202
Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players
Saadat, S., Noureddini, M., Mahjoubin-Tehran, M., Nazemi, S., Shojaie, L., Aschner, M., Maleki, B., Abbasi-kolli, M., Rajabi Moghadam, H., Alani, B., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.588347 · Cited by 179
Chiao, Y. A., & Rabinovitch, P. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025148 · Cited by 200
“Boon et al. (2013) showed that in vivo silencing of miR-34a by injection of antisense oligonucleotides (antagomirs) or locked nucleic acid (LNA)-based anti-miRs can reduce expression of miR-34a and partially rescue cardiac phenotypes in mice.”
BackgroundInfluentialSingh, A., Singh, A., & Sen, D. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0341-0 · Cited by 192
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Roh, J., Hill, J. A., Singh, A., Valero-Muñoz, M., & Sam, F. (2022) · Circulation Research · doi:10.1161/circresaha.122.320257 · Cited by 189
Senescent cells: a therapeutic target for cardiovascular disease
Childs, B. G., Li, H., & van Deursen, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95146 · Cited by 192
“Despite being a largely nondividing cell type, cardiomyocytes from aged rats (66) and mice (67, 68) show telomere shortening, as does healthy human heart tissue (69).”
BackgroundMicroRNA profiling unveils hyperglycaemic memory in the diabetic heart
Costantino, S., Paneni, F., Lüscher, T. F., & Cosentino, F. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv599 · Cited by 190
Genetics and epigenetics of aging and longevity
Moskalev, A., Aliper, A., Smit-McBride, Z., Buzdin, A., & Zhavoronkov, A. (2014) · Cell Cycle · doi:10.4161/cc.28433 · Cited by 187
“has shown that miR-34a is upregulated in the aging heart, and that miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction.(113) The results of Boon et al.”
MicroRNAs as modulators of longevity and the aging process
Kinser, H. E., & Pincus, Z. (2020) · Human Genetics · doi:10.1007/s00439-019-02046-0 · Cited by 178
Heart Failure With Preserved Ejection Fraction: Molecular Pathways of the Aging Myocardium
Loffredo, F. S., Nikolova, A. P., Pancoast, J. R., & Lee, R. T. (2014) · Circulation Research · doi:10.1161/circresaha.115.302929 · Cited by 182
“Predominantly expressed by cardiomyocytes, miR-34a is upregulated in aging mouse hearts as well as in human heart biopsies (≈2-fold).(169) The role of miR-34a in cardiac aging has been linked to regulation of apoptosis.”
BackgroundLyu, G., Guan, Y., Zhang, C., Zong, L., Sun, L., Huang, X., Huang, L., Zhang, L., Tian, X.-L., Zhou, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04994-z · Cited by 176
Baker, J. R., Vuppusetty, C., Colley, T., Papaioannou, A. I., Fenwick, P., Donnelly, L., Ito, K., & Barnes, P. J. (2016) · Scientific Reports · doi:10.1038/srep35871 · Cited by 175
Noncoding RNAs and myocardial fibrosis
Thum, T. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.125 · Cited by 173
Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., Patterson, N. L., & McMullen, J. R. (2018) · Physiological Reviews · doi:10.1152/physrev.00043.2016 · Cited by 160
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
Evangelista, I., Nuti, R., Picchioni, T., Dotta, F., & Palazzuoli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133264 · Cited by 165
“miR-1 [69,75] Downregulated Hypertrophy and oxidative stress Cardiac and skeletal muscle miR-1/206 [71] Upregulated Cardiomyocytes apoptosis Cardiac muscle miR-34a [71,74] Upregulated Cardiomyocytes apoptosis Cardiac muscle miR-133a [69] Downregulated Hypertrophy and oxidative stress Cardiac and skeletal muscle miR-19…”
BackgroundRNA Therapeutics in Cardiovascular Disease
Lucas, T., Bonauer, A., & Dimmeler, S. (2018) · Circulation Research · doi:10.1161/circresaha.117.311311 · Cited by 156
Self-citationBu, P., Wang, L., Chen, K.-Y., Srinivasan, T., Murthy, P. K. L., Tung, K.-L., Varanko, A. K., Chen, H. J., Ai, Y., King, S., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.006 · Cited by 158
“differentiation of embryonic and neural stem cell, somatic cell reprogramming and cardiac aging (Boon et al., 2013; Choi et al., 2011; He et al., 2007; Liu et al., 2011).”
BackgroundHeart failure with preserved ejection fraction in the elderly: scope of the problem
Upadhya, B., Taffet, G. E., Cheng, C. P., & Kitzman, D. W. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.025 · Cited by 170
“The strategy of replacement of miRNAs of interest or of blockade of potentially harmful miRNAs (anti-MIRs) is currently being tested in pre-clinical studies [94].”
BackgroundMicroRNA delivery for regenerative medicine
Peng, B., Chen, Y., & Leong, K. W. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.014 · Cited by 165
“Many cationic lipid-based systems can be selected from a number of commercially available products (Table 3), including Lipofectamine® [139, 141, 142], siPORTTM [143], OligofectamineTM [144], MaxSuppressorTM In Vivo RNA-LANCEr II [76], HiPerFect [77], Lullaby [145], DharmaFECT® [146], SilentFectTM [101] and NeuroPorte…”
MicroRNAs as therapeutic targets in cardiovascular disease
Laggerbauer, B., & Engelhardt, S. H. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159179 · Cited by 167
“miR-34a-5p mimic (MRX-34) Advanced cancer Phase I NCT01829971 (terminated due to serious adverse effects) (107) Mirna Therapeutics (176, 177)”
BackgroundGene Therapy for the Heart Lessons Learned and Future Perspectives
Cannata, A. N., Ali, H., Sinagra, G., & Giacca, M. (2020) · Circulation Research · doi:10.1161/circresaha.120.315855 · Cited by 161
Role of Exosomes in Myocardial Remodeling
Waldenström, A. P., & Ronquist, G. (2014) · Circulation Research · doi:10.1161/circresaha.114.300584 · Cited by 169
Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling
Hofmann, P., Sommer, J., Theodorou, K., Kirchhof, L., Fischer, A., Li, Y., Perisic, L., Hedin, U., Maegdefessel, L., Dimmeler, S., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvy206 · Cited by 147
“To assess aging-induced lncRNA expression regulation in the cardiovascular system, previously published microarray data of organs from young (8 weeks) and aged (18 months) mice were analysed.(52,55) The lncRNA H19 was repressed by aging especially in lung endothelial cells of aged mice compared with young mice, but wa…”
MethodSelf-citationMicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4
Huang, Y., Qi, Y., Du, J.-Q., & Zhang, D.-F. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.961424 · Cited by 140
“Recently, it also been shown found that miR-34a regulates the cardiac contractile function after acute MI [20], and that silencing the miR-34 family by a locked nucleic acid (LNA)modified anti-miR can protect the heart against pathological cardiac remodeling and improve function [21].”
BackgroundMethodInfluentialSilencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice
Zheng, D., Ma, J., Yu, Y., Li, M., Ni, R., Wang, G., Chen, R., Li, J., Fan, G., Lacefield, J. C., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3622-8 · Cited by 150
“Aberrant expression of miRs has been linked to a number of myocardial pathological conditions including hypertrophy, fibrosis, apoptosis, regeneration, arrhythmia and heart failure [10–16].”
BackgroundBhattacharjee, S., Zhao, Y., Dua, P., Rogaev, E. I., & Lukiw, W. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150211 · Cited by 147
“Specific up-regulation of miRNA-34a-signalling has been previously associated with at least 15 neurological, neuroimmune, neuro-inflammatory and/or neurodegenerative pathologies including (i) diseased spinal cord tissues in amyotrophic lateral sclerosis [11]; (ii) peripheral blood mononuclear cells and blood plasma in…”
Han, C., Zhou, J., Liu, B., Liang, C., Pan, X., Zhang, Y., Zhang, Y., Wang, Y., Shao, L., Zhu, B. T., et al. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.122 · Cited by 154
Oligoasthenoteratozoospermia and Infertility in Mice Deficient for miR-34b/c and miR-449 Loci
Comazzetto, S., Giacomo, M. D., Rasmussen, K. D., Much, C., Azzi, C., Perlas, E., Morgan, M., & O’Carroll, D. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004597 · Cited by 155
Crucial Role of miR-433 in Regulating Cardiac Fibrosis
Tao, L., Bei, Y., Chen, P., Lei, Z., Fu, S., Zhang, H., Xu, J., Che, L., Chen, X., Sluijter, J. P., et al. (2016) · Theranostics · doi:10.7150/thno.15007 · Cited by 143
“Increased pro-fibrotic miRNAs such as miR-21, 22, and 34a and decreased anti-fibrotic miRNAs such as miR-24, 15 family, 26a, and 29b have been reported to contribute to cardiac fibrosis [13-20].”
Epigenetics of aging and disease: a brief overview
Pagiatakis, C., Musolino, E., Gornati, R., Bernardini, G., & Papait, R. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01430-0 · Cited by 129
Siemens, H., Jackstadt, R., Kaller, M., & Hermeking, H. (2013) · Oncotarget · doi:10.18632/oncotarget.1202 · Cited by 135
“In addition, miR-34 genes may also be involved in other physiological processes, as for example in aging of the heart [35].”
Self-citationNfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure
Dirkx, E., Gladka, M. M., Philippen, L. E., Armand, A., Kinet, V., Leptidis, S., el Azzouzi, H., Salic, K., Bourajjaj, M., da Silva, G. J. J., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2866 · Cited by 141
Self-citationAtrial fibrillation and microRNAs
Santulli, G., Iaccarino, G., LUCA, N. D., Trimarco, B., & Condorelli, G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00015 · Cited by 142
Nishimura, A., Shimauchi, T., Tanaka, T., Shimoda, K., Toyama, T., Kitajima, N., Ishikawa, T., Shindo, N., Numaga-Tomita, T., Yasuda, S., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aat5185 · Cited by 136
Aging impairs the neurovascular interface in the heart
Wagner, J. U. G., Tombor, L., Malacarne, P. F., Kettenhausen, L.-M., Panthel, J., Kujundzic, H., Manickam, N., Schmitz, K., Cipca, M., Stilz, K. A., et al. (2023) · Science · doi:10.1126/science.ade4961 · Cited by 147
Self-citationDisayabutr, S., Kim, E. K., Cha, S.-I., Green, G., Naikawadi, R. P., Jones, K. D., Golden, J. A., Schroeder, A., Matthay, M. A., Kukreja, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158367 · Cited by 136
“Whether their expression in IPF type II AECs contributes to lung fibrosis in addition to senescence, similar to their purported role in age-related cardiac fibrosis, [53] will require additional study.”
Badi, I., Burba, I., Ruggeri, C., Zeni, F., Bertolotti, M., Scopece, A., Pompilio, G., & Raucci, A. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu180 · Cited by 134
Diagnosis, Prognosis and Therapeutic Role of Circulating miRNAs in Cardiovascular Diseases
Sayed, A. S. M., Xia, K., Salma, U., Yang, T., & Peng, J. (2014) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.01.001 · Cited by 142
Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review
Nappi, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073630 · Cited by 146
Endothelial MicroRNAs and Atherosclerosis
Sun, X., Belkin, N., & Feinberg, M. W. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0372-2 · Cited by 141
“An agerelated increase in miR-34a expression also promoted cardiac senescence by reducing the expression of phosphatase 1 nuclear targeting subunit, a novel miR-34a target [76].”
BackgroundNew Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Bu, L.-L., Yuan, H., Xie, L., Guo, M.-H., Liao, D., & Zheng, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015160 · Cited by 145
Badi, I., Mancinelli, L., Polizzotto, A., Ferri, D., Zeni, F., Burba, I., Milano, G., Brambilla, F., Saccu, C., Bianchi, M. E., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311298 · Cited by 139
“Notably, miR-34a plays an important role during the aging process.(16,17) Indeed, its expression increases in different aged organs and tissues, and its genetic ablation or inhibition in mice has been shown to improve cardiac performance and ventricular remodeling in the aged heart.”
BackgroundChoy, M. S., Hieke, M., Kumar, G. S., Lewis, G. R., Gonzalez-DeWhitt, K. R., Kessler, R. P., Stein, B. J., Hessenberger, M., Nairn, A. C., Peti, W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317395111 · Cited by 129
“In addition, PNUTS was also recently shown to be a target of microRNA miR-34a (17).”
BackgroundXiong, H., Pang, J., Yang, H., Dai, M., Liu, Y., Ou, Y., Huang, Q., Chen, S., Zhang, Z., Xu, Y., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.034 · Cited by 134
Wang, L., Bu, P., Ai, Y., Srinivasan, T., Chen, H. J., Xiang, K., Lipkin, S. M., & Shen, X. (2016) · eLife · doi:10.7554/elife.14620 · Cited by 130
“…shown to regulate stem cell differentiation, somatic stem cell reprogramming, cardiac ageing, neurodegeneration, ciliogenesis, bone resorption, and metabolism (Aranha et al., 2011; Boon et al., 2013; Choi et al., 2011; Krzeszinski et al., 2014; Liu et al., 2012; Song et al., 2014; Xu et al., 2015).”
BackgroundDisrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease
Alibhai, F. J., LaMarre, J., Reitz, C. J., Tsimakouridze, E. V., Kroetsch, J. T., Bolz, S.-S., Shulman, A., Steinberg, S., Burris, T. P., Oudit, G. Y., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.01.008 · Cited by 122
“Moreover, it has been shown that miRNAs also influence cardiac growth pathways and renewal pathways in the heart [46, 47].”
BackgroundLong Noncoding RNA Meg3 Controls Endothelial Cell Aging and Function
Boon, R. A., Hofmann, P., Michalik, K., Lozano‐Vidal, N., Berghäuser, D., Fischer, A., Knau, A., Jaé, N., Schürmann, C., & Dimmeler, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.949 · Cited by 131
Self-citationMicroRNAs as Potential Biomarkers in Atherosclerosis
Churov, A. V., Summerhill, V. I., Grechko, A. V., Orekhova, V. A., & Orekhov, A. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225547 · Cited by 128
“miR-34a PNUTS Regulates cardiac aging and contractile function [141]”
BackgroundOkada, M., Kim, H. W., Matsu-ura, K., Wang, Y.-G., Xu, M., & Ashraf, M. (2015) · Stem Cells · doi:10.1002/stem.2211 · Cited by 135
Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs
Syed, M. A., Das, P., Pawar, A., Aghai, Z. H., Kaskinen, A. K., Zhuang, Z. W., Ambalavanan, N., Pryhuber, G., ANDERSSON, S. M., & Bhandari, V. (2017) · Nature Communications · doi:10.1038/s41467-017-01349-y · Cited by 133
Zhu, B. T., Zhang, L., Liang, C., Liu, B., Pan, X., Wang, Y., Zhang, Y., Zhang, Y., Xie, W., Yan, B., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9739258 · Cited by 136
“Moreover, cell senescence can be induced by several methods including H2O2 [35], D-gal [36], cell cycle inhibition [37], and radiation mutation [38].”
BackgroundDang, Y., Zhao, S., Qin, Y., Han, T., Li, W., & Chen, Z. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.12.106 · Cited by 131
Zhao, Z., Yu, S., Li, M., Gui, X., & Li, P. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05614 · Cited by 122
Feng, Y., Huang, W., Meng, W., Jegga, A. G., Wang, Y., Cai, W., Kim, H. W., Pasha, Z., Wen, Z., Rao, F., et al. (2014) · Stem Cells · doi:10.1002/stem.1571 · Cited by 121
Regulation of longevity by FGF21: interaction between energy metabolism and stress responses
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.004 · Cited by 121
The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas
Adams, B. D., Parsons, C., & Slack, F. J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1114102 · Cited by 127
“SIRT1 [18,23–26] SNAIL [27] IL-6 R [28] MYB [29] CDK4 [29] CDK6 [29] MEK1 [30] E2F3 [31] MYC [23] MET [25,57,64,70,78] BCL2 [23,26,32–34] c-Kit [23] LMTK3 [35] MDM4 [23] Axl [25,41] PNUTS [23,36] Notch1 [37,38] HDAC1 [39] HDAC7 [39] Fra-1 [40,41] VEGF [42] CD44 [43] BCL6 [44] ZFHX1B [44] EXPERT OPINION ON THERAPEUTIC…”
BackgroundNoncoding RNA in age-related cardiovascular diseases
Greco, S., Gorospe, M., & Martelli, F. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.011 · Cited by 120
“MI—Altered levels of circulating miRNAs were detected in patients with AMI, some elevated (miR-1, miR-133, miR-208a/b, miR-499, miR-328), and some reduced (let-7b, miR-126) [153,163,164].”
BackgroundInfluentialNon-coding RNAs in kidney injury and repair
Liu, Z., Wang, Y., Shu, S., Cai, J., Tang, C., & Dong, Z. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00048.2019 · Cited by 122
Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease
Kataoka, M., & Wang, D. (2014) · Cells · doi:10.3390/cells3030883 · Cited by 118
“miR-34 PPP1R10, vinculin, Sema4b, Pofut1, Bcl6 myocardial infarction, cardiac hypertrophy [57,58]”
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.